Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Department of Infectious Diseases, Apollo Hospitals, Chennai, India.
Indian J Med Res. 2019 Feb;149(2):180-184. doi: 10.4103/ijmr.IJMR_147_18.
Antimicrobial resistance (AMR) in India has become a great threat because of high rate of infectious diseases. One of the key contributing factors is high antibiotic use due to poor prescription practices, self-medication, over-the-counter sale of drugs and lack of awareness. Antimicrobial stewardship programme (AMSP) have been proved to be successful in restraining sale and use of antibiotics to a large extent in many countries. An AMSP programme for a hospital is imperative for rational and evidence-based antimicrobial therapy. The ultimate aim is to improve patient outcomes, reduce emergence of bacterial resistance and ensure longevity of the existing antimicrobials. The primary goal of AMSP is to encourage cautious use of available antibiotics by training the healthcare workers and creating awareness. This article describes the strategies and recommendations for formulation of AMSP policy for India.
印度的抗菌素耐药性（AMR）由于传染病发病率高而成为一个巨大的威胁。造成这种情况的一个关键因素是抗生素的大量使用，这是由于处方实践不当、自我用药、药物的非处方销售以及缺乏意识所致。抗菌药物管理计划（AMSP）已被证明在许多国家在很大程度上成功地限制了抗生素的销售和使用。为了实现合理和基于证据的抗菌治疗，医院的抗菌药物管理计划势在必行。其最终目标是改善患者的治疗效果，减少细菌耐药性的出现，并确保现有抗菌药物的有效性。抗菌药物管理计划的主要目标是通过培训医务人员和提高认识来鼓励谨慎使用现有的抗生素。本文介绍了制定印度抗菌药物管理计划政策的策略和建议。
